ReviewOncoTargets and therapy2018

Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment.

Hongge Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.